End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
36.32 CNY | +2.77% | +0.55% | -29.73% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-29.73% | 419M | - | ||
+4.76% | 105B | A- | ||
-6.59% | 62.52B | A- | ||
+72.86% | 49.08B | B | ||
+16.94% | 38.99B | B | ||
+5.28% | 32.59B | A- | ||
+14.48% | 20.6B | B- | ||
+15.10% | 17.19B | C+ | ||
+18.07% | 15.13B | B- | ||
+4.83% | 14.36B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 688357 Stock
- Ratings Luoyang Jianlong Micro-nano New Material Co., Ltd